National Coverage Determination (NCD) 210.3 - Screening for Colorectal Cancer (CRC) - Blood-Based Biomarker Tests
This new Article comprises Subregulatory Guidance for blood-based biomarker tests. Effective January 19, 2021, the blood-based biomarker test is an appropriate CRC screening test based on specific criteria.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: May 26, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.